- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 86.07M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 85.7M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 86.1M sh |
| Capex | Q1 2025 · Mar 31, 2025 | $9M |
| Capex | Q1 2025 · Mar 31, 2024 | $6M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | $14M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $38M |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $367M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $384M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $4M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $3M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $525M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $516M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $495M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $488M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $593M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $508M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $999M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $921M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.7B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.62B |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | −$0.26 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.15 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | −$0.26 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.15 |
| Sga Expense | Q1 2025 · Mar 31, 2025 | $124M |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $120M |
| Net Income | Q1 2025 · Mar 31, 2025 | −$22M |
| Net Income | Q1 2025 · Mar 31, 2024 | $19M |
| Operating Income | Q1 2025 · Mar 31, 2025 | $18M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $39M |
| Gross Profit | Q1 2025 · Mar 31, 2025 | $142M |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $159M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2025 | $570M |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $618M |
| Revenue | Q1 2025 · Mar 31, 2025 | $712M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $777M |